{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-24-015608","form_type":"8-K","ticker":"PLX","cik":"0001006281","company_name":"Protalix BioTherapeutics, Inc.","filed_at":"2024-11-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.333661+00:00","generated_at":"2026-05-30T00:11:22.604259+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Protalix Q3 net income $3.2M, revenue up 75%; PRX-115 Phase I positive","bullets":["Revenue from goods $17.8M (+75% YoY); net income $3.2M vs loss $1.9M in Q3 2023; EPS $0.04 basic.","PRX-115 Phase I completed all eight cohorts; single dose lowered uric acid below 6.0 mg/dL for up to 12 weeks at highest doses.","PRX-115 well-tolerated: 25% of treated subjects reported mild-to-moderate AEs; one resolved anaphylactic reaction.","Cash $27.4M at Sept 30; repaid 7.5% senior secured convertible notes due Sept 2024 from available cash.","Planning phase II trial of PRX-115 in gout patients, initiation expected H2 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-24-015608","json":"https://secwatch.observer/filing/0001558370-24-015608.json","markdown":"https://secwatch.observer/filing/0001558370-24-015608.md","text":"https://secwatch.observer/filing/0001558370-24-015608.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1006281/000155837024015608/0001558370-24-015608-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1006281/000155837024015608/plx-20241114x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T00:11:22.604259+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}